In addition, tau hyper-phosphorylation in AD is mediated by increased activation of cyclin-dependent kinase 5 (cdk-5) and c-Abl kinases [59, 60], and inhibition of protein phosphatases 1 and 2A [41, 60, 61]. The gene discussed is MAPT; the disease is Alzheimer disease.